Virtus ETF Advisers LLC - Q2 2016 holdings

$135 Million is the total value of Virtus ETF Advisers LLC's 147 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .

 Value Shares↓ Weighting
CQP NewCHENIERE ENERGY PARTNERS LP$350,00011,685
+100.0%
0.26%
NERV NewMINERVA NEUROSCIENCES INC$262,00025,630
+100.0%
0.19%
ITCI NewINTRA CELLULAR THERAPIES INC$250,0006,443
+100.0%
0.19%
BGNE NewBEIGENE LTDsponsored adr$249,0008,344
+100.0%
0.18%
ARWR NewARROWHEAD PHARMACEUTICALS IN$230,00043,272
+100.0%
0.17%
AGTC NewAPPLIED GENETIC TECHNOL CORP$229,00016,223
+100.0%
0.17%
AVXS NewAVEXIS INC$223,0005,869
+100.0%
0.16%
OKE NewONEOK INC NEW$113,0002,378
+100.0%
0.08%
NewSTATE STR CORP$9,000150
+100.0%
0.01%
NewSTATE STR CORP$2,000300
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC31Q3 20231.7%
REGENERON PHARMACEUTICALS31Q3 20231.8%
INCYTE CORP31Q3 20232.1%
ENANTA PHARMACEUTICALS INC31Q3 20232.2%
EXELIXIS INC31Q3 20231.8%
VANDA PHARMACEUTICALS INC31Q3 20231.7%
IRONWOOD PHARMACEUTICALS INC31Q3 20232.0%
LIGAND PHARMACEUTICALS INC31Q3 20231.5%
GILEAD SCIENCES INC31Q3 20231.6%
HALOZYME THERAPEUTICS INC31Q3 20231.7%

View Virtus ETF Advisers LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-15
13F-HR2023-11-07
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Virtus ETF Advisers LLC's complete filings history.

Compare quarters

Export Virtus ETF Advisers LLC's holdings